Barr E S & Co
- SEC CIK
- 0001040210
- Latest filing
- Aug 13, 2026
ZNTL holding history
Zentalis Pharmaceuticals, Inc. in every 13F filed by Barr E S & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZNTL overviewAll 13F holders of ZNTLFull Q2 2026 holdings
- Shares (Q2 2026)
- 110,000
- Value
- $533.5K
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 110,000 | $533.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 110,000 | $257.4K | <0.1% | +52,500+91.3% | Added | Holders |
| Q4 2025 | 57,500 | $77.6K | <0.1% | +17,500+43.8% | Added | Holders |
| Q3 2025 | 40,000 | $60.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 40,000 | $46.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 40,000 | $63.6K | <0.1% | +40,000 | New | Holders |